SOCRA CCRP Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Master the SOCRA CCRP Exam with our comprehensive practice quiz. Tailored feedback, detailed explanations, and real-world scenarios to boost your confidence and success.

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Which is NOT a common issue the FDA finds during site inspection?

Excessive patient compensation
Protocol deviations
Failure to follow investigational plan and signed investigator agreement
Inadequate recordkeeping

The correct answer is: Excessive patient compensation

During site inspections, the FDA looks for any issues that may impact the safety, efficacy, and integrity of clinical trials. Excessive patient compensation is not a common issue the FDA finds during site inspections, as long as it is within the approved budget and not used as an incentive for participation. This option is incorrect because the other choices, including protocol deviations, failure to follow investigational plan and signed investigator agreement, and inadequate recordkeeping, are all common issues that the FDA frequently finds during site inspections. These issues can affect the validity and reliability of the trial results, and can also pose risks to the safety of study participants. Therefore, they are important for the FDA to identify and address during site inspections.